rs7661020

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_016599.5(MYOZ2):​c.561-139T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 726,368 control chromosomes in the GnomAD database, including 35,571 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.27 ( 6239 hom., cov: 32)
Exomes 𝑓: 0.31 ( 29332 hom. )

Consequence

MYOZ2
NM_016599.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.360

Publications

9 publications found
Variant links:
Genes affected
MYOZ2 (HGNC:1330): (myozenin 2) The protein encoded by this gene belongs to a family of sarcomeric proteins that bind to calcineurin, a phosphatase involved in calcium-dependent signal transduction in diverse cell types. These family members tether calcineurin to alpha-actinin at the z-line of the sarcomere of cardiac and skeletal muscle cells, and thus they are important for calcineurin signaling. Mutations in this gene cause cardiomyopathy familial hypertrophic type 16, a hereditary heart disorder. [provided by RefSeq, Aug 2011]
MYOZ2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 16
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 4-119185827-T-C is Benign according to our data. Variant chr4-119185827-T-C is described in ClinVar as Benign. ClinVar VariationId is 674345.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.507 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYOZ2NM_016599.5 linkc.561-139T>C intron_variant Intron 5 of 5 ENST00000307128.6 NP_057683.1 Q9NPC6
MYOZ2NM_001440645.1 linkc.607-139T>C intron_variant Intron 6 of 6 NP_001427574.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYOZ2ENST00000307128.6 linkc.561-139T>C intron_variant Intron 5 of 5 1 NM_016599.5 ENSP00000306997.6 Q9NPC6

Frequencies

GnomAD3 genomes
AF:
0.274
AC:
41703
AN:
151980
Hom.:
6241
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.327
Gnomad AMR
AF:
0.277
Gnomad ASJ
AF:
0.203
Gnomad EAS
AF:
0.523
Gnomad SAS
AF:
0.231
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.328
Gnomad OTH
AF:
0.294
GnomAD4 exome
AF:
0.313
AC:
179599
AN:
574272
Hom.:
29332
AF XY:
0.308
AC XY:
93681
AN XY:
304186
show subpopulations
African (AFR)
AF:
0.169
AC:
2479
AN:
14626
American (AMR)
AF:
0.297
AC:
7386
AN:
24854
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
3646
AN:
17662
East Asian (EAS)
AF:
0.495
AC:
15751
AN:
31852
South Asian (SAS)
AF:
0.217
AC:
11349
AN:
52300
European-Finnish (FIN)
AF:
0.261
AC:
8191
AN:
31424
Middle Eastern (MID)
AF:
0.217
AC:
495
AN:
2286
European-Non Finnish (NFE)
AF:
0.329
AC:
121096
AN:
368490
Other (OTH)
AF:
0.299
AC:
9206
AN:
30778
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
6551
13102
19653
26204
32755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1590
3180
4770
6360
7950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.274
AC:
41722
AN:
152096
Hom.:
6239
Cov.:
32
AF XY:
0.273
AC XY:
20297
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.166
AC:
6904
AN:
41486
American (AMR)
AF:
0.277
AC:
4242
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.203
AC:
703
AN:
3464
East Asian (EAS)
AF:
0.523
AC:
2712
AN:
5182
South Asian (SAS)
AF:
0.230
AC:
1109
AN:
4820
European-Finnish (FIN)
AF:
0.265
AC:
2806
AN:
10582
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.328
AC:
22270
AN:
67960
Other (OTH)
AF:
0.292
AC:
614
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1485
2970
4454
5939
7424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
438
876
1314
1752
2190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.308
Hom.:
6841
Bravo
AF:
0.278
Asia WGS
AF:
0.314
AC:
1090
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.5
DANN
Benign
0.81
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7661020; hg19: chr4-120106982; API